Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating an interface or backend release without altering the study record content.SummaryDifference0.1%

- Check9 days agoChange Detected- Website revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; this update does not change any study details, eligibility criteria, locations, or outcomes displayed on the page.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision number updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 has been added, and the previous funding/operating status notice (Revision: v3.4.1) has been removed.SummaryDifference0.5%

- Check80 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operating status was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.